申请人:Daiichi Sankyo Company, Limited
公开号:EP2204365A1
公开(公告)日:2010-07-07
[Object] To provide a compound which has activity to inhibit production and/or secretion of β-amyloid protein, and is useful for prevention and/or treatment of various diseases associated with abnormal production and/or secretion of β-amyloid protein.
[Means for Solution]
A compound represented by the general formula (I):
[wherein, R1 represents a C1-C6 alkyl group which may have 1 to 6 halogen atoms as substituent groups, a C2-C6 alkenyl group which may have 1 to 6 halogen atoms as substituent groups, or a C3-C7 cycloalkyl group which may have 1 to 6 halogen atoms as substituent groups; R2 represents a 6-membered nitrogen-containing monocyclic aromatic heterocyclic group having 1 to 3 substituent groups, or a 9- or 10-membered nitrogen-containing bicyclic heterocyclic group having 1 to 4 substituent groups; Z1, Z2 and Z3 each independently represent a hydrogen atom, a halogen atom or a cyano group; and n represents 0, 1 or 2], salts thereof, or solvates thereof.
[目的]提供一种化合物,该化合物具有抑制β-淀粉样蛋白产生和/或分泌的活性,可用于预防和/或治疗与β-淀粉样蛋白异常产生和/或分泌有关的各种疾病。
[解决方法]
一种由通式 (I) 表示的化合物:
[其中,R1 代表可具有 1 至 6 个卤素原子作为取代基的 C1-C6 烷基、可具有 1 至 6 个卤素原子作为取代基的 C2-C6 烯基或可具有 1 至 6 个卤素原子作为取代基的 C3-C7 环烷基;R2代表具有 1 至 3 个取代基的 6 元含氮单环芳香杂环基团,或具有 1 至 4 个取代基的 9 元或 10 元含氮双环杂环基团;Z1、Z2 和 Z3 各自独立地代表氢原子、卤素原子或氰基;以及 n 代表 0、1 或 2]、其盐或其溶剂。